Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
---|---|---|---|---|---|
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 3687 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 3942 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 5817 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 10796 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 10839 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 11397 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 12431 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 14719 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 20139 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 22950 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 24578 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 26024 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 29799 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 38685 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 40030 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 71402 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 72165 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 81616 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 85246 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 86923 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 89972 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 98096 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 109276 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 109805 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 110519 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 112227 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 121108 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 121762 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 122929 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 124526 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 134011 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 140182 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 144064 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 148444 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 150249 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 153050 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 154713 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 155226 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 157105 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 159891 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 160183 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 160932 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 161506 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 162157 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 162622 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 162933 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 162935 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 163462 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 163753 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 163966 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 164181 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 164255 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 164496 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 164645 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 165436 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 165522 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 165651 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 165895 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 166041 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 166079 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 166706 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 166764 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167221 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167255 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167299 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167301 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167684 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167686 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167695 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167730 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167768 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167855 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167864 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 167998 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 168409 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 168438 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 168597 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 168861 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 168919 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 169043 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 169776 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 169779 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 169856 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 170669 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 170733 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 171563 | Peak area normalized | batch pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 171648 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 173144 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 173181 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 173715 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 174270 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 175869 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 176885 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 180889 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 182665 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 184286 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 186487 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 187851 | Peak area normalized | master pool | - |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 188128 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 189149 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 191351 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 192963 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 194048 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 198328 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 199785 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 201067 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 202163 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 204327 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 205021 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 206656 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 206904 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 206971 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 207745 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 210086 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 210831 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 216421 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 216491 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 219841 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 221352 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 223425 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 226834 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 228583 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 229175 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 231474 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 234830 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 236281 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 241375 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 241581 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 242038 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 242225 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 242860 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 242985 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 243345 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 244923 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 246635 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 248322 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 249401 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 249415 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 254592 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 256741 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 257124 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 259681 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 261574 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 262110 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 263089 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 263303 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 263796 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 268176 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 268333 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 268394 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 269287 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 270398 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 272001 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 272402 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 272619 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 274567 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 276152 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 279731 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 280532 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 281658 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 281958 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 282846 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 286892 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 293048 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 294164 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 298670 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 300356 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 302812 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 306275 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 310044 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 311961 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 316109 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 318919 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 322113 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 326510 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 326624 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 327607 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 328753 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 330488 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 344530 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 345068 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 348531 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 348923 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 348954 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 353041 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 357614 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 359627 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 360979 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 364752 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 366630 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 370512 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 378009 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 384623 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 386411 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 391986 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 392657 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 396182 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 397461 | Peak area normalized | Sample | male |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 398210 | Peak area normalized | Sample | female |
Reversed Phase POSITIVE (Named metabolites) | biliverdin | 399210 | Peak area normalized | Sample | male |
Return to search page